J-Lex

Cataclot injection 40mg

Cataclot injection 40mg, manufactured by Maruishi Pharmaceutical, contains sodium ozagrel, an antiplatelet drug. It is indicated for use after surgery for subarachnoid hemorrhage and to treat cerebral thrombosis. The product is 40mg 5mL 1 tube, YJ code 3999411H3026.

← Back to search

Need more detailed information?

Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).

More with the same ingredient

More from this manufacturer